Independent fund research. Built on SEC filings.

How we research funds

ETF · Corporate Bond · Fidelity

IBD Performance & Returns History

Ticker IBD · Since 2017-07-10 · · Holdings as of May 31, 2026

Expense ratio
0.41%$41/yr per $10k
5-yr return
+1.0%annualized
1-yr return
+7.1%as of Dec 2025
Net assets
$466.8Mall share classes
Holdings
252

Bottom line

How has IBD performed?

As of Dec 31, 2025, IBD returned +7.1% over the past year, +1.0% a year over five years. That means $10,000 invested five years earlier would have grown to about $10,500. Its five-year return beat 82% of corporate bond funds we track. Its best quarter was +8.3% and its worst −5.2%.

Updated Dec 31, 2025

IBD annual returns by year

IBD calendar-year returns 2018: −0.2%; 2019: +8.3%; 2020: +5.2%; 2021: −1.7%; 2022: −9.3%; 2023: +6.4%; 2024: +3.6%; 2025: +7.1% −0% 2018 +8% 2019 +5% 2020 −2% 2021 −9% 2022 +6% 2023 +4% 2024 +7% 2025
Fund gain (+) Fund loss (−)
Year20252024202320222021202020192018
IBD+7.1%+3.6%+6.4%−9.3%−1.7%+5.2%+8.3%−0.2%

Source: Fund prospectus bar chart (risk/return summary)

Growth of $10,000 in IBD

$10,000 invested at the start of 2018 would have been worth about $12,000 by the end of 2025, based on the fund's reported calendar-year returns.

YearReturnValue of $10,000
2025+7.1%$11,971
2024+3.6%$11,175
2023+6.4%$10,789
2022−9.3%$10,137
2021−1.7%$11,170
2020+5.2%$11,368
2019+8.3%$10,805
2018−0.2%$9,976

Trailing returns vs benchmark and category

1 yr5 yr10 yrSince inception
IBD+7.1%+1.0%—+2.2%
Corporate Bond median+7.1%−0.0%+3.0%—

Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com

Recent monthly returns

For the three months ending May 31, 2026, IBD returned −1.43%, +0.46%, +0.29% (oldest to newest), per SEC Form N-PORT.

Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.